SINGAPORE, Sept. 4 (Xinhua) -- Nearly 50 suspected cases of etomidate-linked vaping were recorded at Singapore's public healthcare institutions in six weeks starting July 9, the Ministry of Health said.
On July 9, the ministry directed public healthcare providers to document all suspected and confirmed cases, amid a rise in the number of vapes laced with etomidate over the past year.
A ministry spokesperson said enforcement action would not be taken against individuals for past vape use if they voluntarily sought medical help.
Singapore has intensified its crackdown on vaping, particularly against the emerging trend of e-vaporizers containing harmful substances such as etomidate. On Aug. 28, authorities announced that from Sept. 1, etomidate would be classified as a Class C controlled drug for six months, pending the introduction of more comprehensive legislation by the ministry.
With the change, those who import, sell or distribute etomidate-laced e-vaporizers face prosecution and heavier penalties. Individuals found using such devices or testing positive for etomidate will also face stricter consequences beyond fines.
